These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 18070982)

  • 1. TRAF6 distinctively mediates MyD88- and IRAK-1-induced activation of NF-kappaB.
    Muroi M; Tanamoto K
    J Leukoc Biol; 2008 Mar; 83(3):702-7. PubMed ID: 18070982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syntenin negatively regulates TRAF6-mediated IL-1R/TLR4 signaling.
    Chen F; Du Y; Zhang Z; Chen G; Zhang M; Shu HB; Zhai Z; Chen D
    Cell Signal; 2008 Apr; 20(4):666-74. PubMed ID: 18234474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutive association of MyD88 to IRAK in HTLV-I-transformed T cells.
    Mizobe T; Tsukada J; Higashi T; Mouri F; Matsuura A; Tanikawa R; Minami Y; Yoshida Y; Tanaka Y
    Exp Hematol; 2007 Dec; 35(12):1812-22. PubMed ID: 17920759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interference with nuclear factor kappa B and c-Jun NH2-terminal kinase signaling by TRAF6C small interfering RNA inhibits myeloma cell proliferation and enhances apoptosis.
    Chen H; Li M; Campbell RA; Burkhardt K; Zhu D; Li SG; Lee HJ; Wang C; Zeng Z; Gordon MS; Bonavida B; Berenson JR
    Oncogene; 2006 Oct; 25(49):6520-7. PubMed ID: 16702955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel splice variant of mouse interleukin-1-receptor-associated kinase-1 (IRAK-1) activates nuclear factor-kappaB (NF-kappaB) and c-Jun N-terminal kinase (JNK).
    Yanagisawa K; Tago K; Hayakawa M; Ohki M; Iwahana H; Tominaga S
    Biochem J; 2003 Feb; 370(Pt 1):159-66. PubMed ID: 12418963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRAF6 is a signal transducer for interleukin-1.
    Cao Z; Xiong J; Takeuchi M; Kurama T; Goeddel DV
    Nature; 1996 Oct; 383(6599):443-6. PubMed ID: 8837778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRAF6 negatively regulates TNFalpha-induced NF-kappaB activation.
    Funakoshi-Tago M; Kamada N; Shimizu T; Hashiguchi Y; Tago K; Sonoda Y; Kasahara T
    Cytokine; 2009 Feb; 45(2):72-9. PubMed ID: 19091594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MyD88-induced downregulation of IRAK-4 and its structural requirements.
    Hatao F; Yamamoto M; Muroi M; Kaminishi M; Tanamoto K
    FEMS Immunol Med Microbiol; 2008 Jul; 53(2):260-4. PubMed ID: 18503546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRAF6 activation of PI 3-kinase-dependent cytoskeletal changes is cooperative with Ras and is mediated by an interaction with cytoplasmic Src.
    Wang KZ; Wara-Aswapati N; Boch JA; Yoshida Y; Hu CD; Galson DL; Auron PE
    J Cell Sci; 2006 Apr; 119(Pt 8):1579-91. PubMed ID: 16569657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The TLR2 ligand FSL-1 and the TLR5 ligand Flagellin mediate pro-inflammatory and pro-labour response via MyD88/TRAF6/NF-κB-dependent signalling.
    Lim R; Barker G; Lappas M
    Am J Reprod Immunol; 2014 May; 71(5):401-17. PubMed ID: 24635133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of IRAK-1 activation by its C-terminal domain.
    Nguyen T; De Nardo D; Masendycz P; Hamilton JA; Scholz GM
    Cell Signal; 2009 May; 21(5):719-26. PubMed ID: 19166926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micrococci and peptidoglycan activate TLR2-->MyD88-->IRAK-->TRAF-->NIK-->IKK-->NF-kappaB signal transduction pathway that induces transcription of interleukin-8.
    Wang Q; Dziarski R; Kirschning CJ; Muzio M; Gupta D
    Infect Immun; 2001 Apr; 69(4):2270-6. PubMed ID: 11254583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HSP27 regulates IL-1 stimulated IKK activation through interacting with TRAF6 and affecting its ubiquitination.
    Wu Y; Liu J; Zhang Z; Huang H; Shen J; Zhang S; Jiang Y; Luo L; Yin Z
    Cell Signal; 2009 Jan; 21(1):143-50. PubMed ID: 18950704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus X protein stimulates IL-6 expression in hepatocytes via a MyD88-dependent pathway.
    Xiang WQ; Feng WF; Ke W; Sun Z; Chen Z; Liu W
    J Hepatol; 2011 Jan; 54(1):26-33. PubMed ID: 20937539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct molecular mechanism for initiating TRAF6 signalling.
    Ye H; Arron JR; Lamothe B; Cirilli M; Kobayashi T; Shevde NK; Segal D; Dzivenu OK; Vologodskaia M; Yim M; Du K; Singh S; Pike JW; Darnay BG; Choi Y; Wu H
    Nature; 2002 Jul; 418(6896):443-7. PubMed ID: 12140561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-1 receptor-associated kinase (IRAK) -1-mediated NF-kappaB activation requires cytosolic and nuclear activity.
    Liu G; Park YJ; Abraham E
    FASEB J; 2008 Jul; 22(7):2285-96. PubMed ID: 18276832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IRAK-1-mediated negative regulation of Toll-like receptor signaling through proteasome-dependent downregulation of TRAF6.
    Muroi M; Tanamoto K
    Biochim Biophys Acta; 2012 Feb; 1823(2):255-63. PubMed ID: 22033459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutaredoxin-1 regulates TRAF6 activation and the IL-1 receptor/TLR4 signalling.
    Chantzoura E; Prinarakis E; Panagopoulos D; Mosialos G; Spyrou G
    Biochem Biophys Res Commun; 2010 Dec; 403(3-4):335-9. PubMed ID: 21078302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IRAK-4-dependent degradation of IRAK-1 is a negative feedback signal for TLR-mediated NF-kappaB activation.
    Kubo-Murai M; Hazeki K; Nigorikawa K; Omoto T; Inoue N; Hazeki O
    J Biochem; 2008 Mar; 143(3):295-302. PubMed ID: 18079163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired cytokine signaling in mice lacking the IL-1 receptor-associated kinase.
    Thomas JA; Allen JL; Tsen M; Dubnicoff T; Danao J; Liao XC; Cao Z; Wasserman SA
    J Immunol; 1999 Jul; 163(2):978-84. PubMed ID: 10395695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.